A carregar...
Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX
The development of alloantibodies neutralising therapeutically administered factor (F) VIII/IX (inhibitors) is currently the most severe complication of the treatment of haemophilia. When persistent and at a high titre, inhibitors preclude the standard replacement treatment with FVIII/FIX concentrat...
Na minha lista:
Publicado no: | J Clin Med |
---|---|
Main Authors: | , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
MDPI
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5406778/ https://ncbi.nlm.nih.gov/pubmed/28420167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm6040046 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|